BioSpace News Archive

MicroGen Diagnostics , the industry leader in providing next-generation DNA sequencing (NGS) for clinical diagnostics, has introduced OrthoKEY, an innovative approach to address current clinical shortcomings in the diagnosis of orthopedic infections.

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced the appointment of Ms. Kathryn Gregory as Vice President and Head of Corporate Business Development

Ascletis Pharma Inc. (HKEX code: 1672) today announces that following the consultation with China National Medical Products Administration (NMPA), the clinical trial application of ASC40 combined with bevacizumab to treat patients with recurrent glioblastoma (rGBM) has been accepted for review by China NMPA.

Surrozen Inc., a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, announced today that data from preclinical studies of its two lead Wnt-modulating antibody programs were presented in six oral and poster presentations during Digestive Disease Week 2021 .

Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, has today announced that the first patient has been enrolled in its MEND (MEseNchymal coviD-19) clinical trial.

Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus, announced that Lisa Johnson-Pratt, M.D., has joined the company’s board of directors.

Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional patent with the U.S. Patent and Trademark Office (USPTO) titled “Bio-Targeted Radiopharmaceutical Compositions Containing Ac-225 and Methods of Preparation.”

A new research paper, funded by the Reboot Foundation, outlines effective strategies for combating misinformation campaigns, particularly around the COVID-19 pandemic.

Qelbree™ has proven efficacy in ADHD, with improvement in symptoms as early as the first week

Transparency Market Research has published a new report titled “Shock Wave Therapy Device Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.